People: IRIDEX Corp (IRIX.W)
IRIX.W on CBOE When Trading NASDAQ Global Select Market
6.48USD
20 May 2013
6.48USD
20 May 2013
Price Change (% chg)
$1.74 (+36.71%)
$1.74 (+36.71%)
Prev Close
$4.74
$4.74
Open
$6.48
$6.48
Day's High
$6.48
$6.48
Day's Low
$6.48
$6.48
Volume
100
100
Avg. Vol
6
6
52-wk High
$6.48
$6.48
52-wk Low
$3.12
$3.12
Summary
| Name | Age | Since | Current Position |
|---|---|---|---|
William Moore |
63 | 2012 | Chairman of the Board, Interim President and Chief Executive Officer |
James Mackaness |
48 | 2012 | Chief Financial Officer, Chief Operating Officer |
Eduardo Arias |
68 | 2012 | Senior Vice President - Global Sales |
Scott Shuda |
47 | 2012 | Director |
Sanford Fitch |
71 | 2004 | Independent Director |
Garrett Garrettson |
69 | 2010 | Independent Director |
James Hawkins |
56 | 2007 | Independent Director |
Ruediger Naumann-Etienne |
66 | 2009 | Independent Director |
Biographies
| Name | Description |
|---|---|
William Moore |
Mr. William M. Moore serves as Chairman of the Board, Interim President and Chief Executive Officer of Iridex Corp. Moore co-founded Natus Medical Incorporated, a public company, in 1990 where he served as CEO until 1993. Natus Medical is a provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments such as hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and certain newborn conditions. Mr. Moore still serves on the Natus Board of Directors. Moore also served as a consultant to BlueLine Partners, a private equity firm and investor in IRIDEX, from February 2004 until June 2008. He also served on the Board of Directors of Urologix, Inc., a public medical device company. Moore holds a B.S. in Business from the University of Utah. |
James Mackaness |
Mr. James H. Mackaness is Chief Financial Officer, Chief Operating Officer of Iridex Corp. Mackaness served as Chief Financial Officer and Vice President of Finance of NextHop Technologies, Inc., a networking wireless technology company from September 2001 to December 2007. Prior to that, he served as Vice President, Finance and Chief Financial Officer of Infogear Technologies Corporation and held management positions at Cisco Systems, Inc. and Ernst & Young LLP. Mackaness received his B.A. with honors in Psychology from the University of Warwick, England and is a Chartered Accountant and member of the Institute of Chartered Accountants of England and Wales. |
Eduardo Arias |
Mr. Eduardo Arias is Senior Vice President - Global Sales of Iridex Corp. Mr. Arias co-founded the Company and served as Vice President, Sales & Marketing from April 1989 until September 1991 when he was promoted to the position of Senior Vice President, Worldwide Sales. He was promoted to Senior Vice President, International Sales and Business Development in January 2002 and served in that capacity until October 2012 when he assumed responsibility for Global Sales. Prior to co-founding the Company, Mr. Arias held various positions, including Director of Marketing and Sales, Medical Group and Director of International Operations, at Coherent, Inc. |
Scott Shuda |
Mr. Scott A. Shuda has been appointed as Director of Iridex Corp., effective December 5, 2012. Mr. Shuda is the co-founder and Managing Director of BlueLine Partners, LLC, a special situations investment firm that focuses on publicly listed technology and healthcare companies. Prior to co-founding BlueLine Partners in 2003, Mr. Shuda served as General Counsel and Secretary to Vicinity Corporation, an online provider of enterprise location services and speech platforms, from 1999 until its acquisition by Microsoft in 2002, and prior to that Mr. Shuda was employed as an attorney in New York City and Silicon Valley. Mr. Shuda was also a director of MGC Diagnostics Corporation (formerly Angeion Corporation), a global medical technology company dedicated to cardio-respiratory health solutions, from 2010 to May 2011. Mr. Shuda has a law degree and a master of business administration degree from Georgetown University. |
Sanford Fitch |
Mr. Sanford Fitch is Independent Director of Iridex Corp. Mr. Fitch has served as a director and Audit Committee Chairman of Masimo Corp, a public company that designs, develops, manufactures and sells medical devices, since November 2006. Mr. Fitch also currently serves as a director of Ozone International, Inc., a privately held technology company. Mr. Fitch served as a director and Audit Committee Chairman of Foxhollow Technologies, Inc., a public company that designed, developed, manufactured and sold medical devices, from June 2004 until October 2007. He also served as a director and Audit Committee Chairman of Conceptus Inc., a public medical device company, from December 1994 until April 2004. Mr. Fitch was Chief Financial Officer and Senior Vice President of Operations of Conceptus from December 1994 through October 1998 and took the company public in 1996. Mr. Fitch also served as Chief Financial Officer of several start-up technology companies from 1998 until 2002. From December 1990 to January 1994, Mr. Fitch served as Chief Financial Officer of SanDisk Corp., a manufacturer of flash memory devices. From 1983 through 1989, Mr. Fitch was the Chief Financial Officer of Komag Inc., a manufacturer of rigid thin film media for the disk drive industry, and took the company public in 1987. Mr. Fitch holds a B.S. in Chemistry and an M.B.A. from Stanford University. |
Garrett Garrettson |
Dr. Garrett A. Garrettson, Ph.D., is Independent Director of Iridex Corp. He has served as a director of the Company since 2004 and served as Lead Independent Director and then Chairman of the Company’s Board of Directors from January 2008 to September 2010. Dr. Garrettson is currently a principal of G. Garrettson Consulting, a management consulting company, and of daVinci Capital Group, a private equity fund being formed. From December 2005 to January 2008, Dr. Garrettson was CEO of Fresco Technologies, a privately held digital imaging company. From 2001 until 2004, Dr. Garrettson was the President and Chief Executive Officer of ClairVoyante, a privately held company that develops and licenses proprietary intellectual property to flat panel display manufacturers and that was purchased by Samsung. Prior to this, Dr. Garrettson was affiliated with Spectrian Corporation, a manufacturer of high power radio frequency transistors and amplifiers for wireless network equipment, where Dr. Garrettson served as President and Chief Executive Officer from 1996 to 2000 and as Chairman of the Board from 2000 to 2002. Before joining Spectrian, Dr. Garrettson served as the President and Chief Executive Officer of Censtor Corporation, a developer of contact magnetic recording head disc technology for the data storage industry, from 1993 to 1996. From 1989 to 1993, Dr. Garrettson had various assignments in Seagate Technology, a maker of hard disc drives and storage systems, including GM of the Enterprise Storage Division and VP of Strategic Marketing and Corporate Development. Dr. Garrettson holds an M.S. in Engineering Physics as well as a Ph.D. in Nuclear Engineering from Stanford University. |
James Hawkins |
Mr. James B. Hawkins is Independent Director of Iridex Corp. Since April 2004, Mr. Hawkins has served as the President, Chief Executive Officer, and a director of Natus Medical Incorporated, a provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments such as hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and certain newborn conditions. Prior to joining Natus Medical, Mr. Hawkins was President, Chief Executive Officer, and a director of Invivo Corporation, a developer and manufacturer of multi-parameter vital sign monitoring equipment, and its predecessor from 1985 through January 2004. Mr. Hawkins also served as Secretary of Invivo from 1986 until January 2004. Mr. Hawkins holds an undergraduate degree in Business Commerce from Santa Clara University and holds an M.B.A. from San Francisco State University. |
Ruediger Naumann-Etienne |
Dr. Ruediger Naumann-Etienne, Ph.D., is Independent Director of Iridex Corp. Dr. Naumann-Etienne has been the owner and Managing Director of Intertec Group, an investment company specializing in the medical device field, since 1989. He was Chairman of Cardiac Science Corporation from 2006 until the company was sold to Opto Electronics of India in 2010. From 2000 to 2005, Dr. Naumann-Etienne served as Chairman of Quinton Cardiology Systems, one of the predecessor companies of Cardiac Science. From 2000 to 2003, he also served as Chief Executive Officer of this company. From 1993 until 1999, Dr. Naumann-Etienne was Chairman of OEC Medical Systems, a manufacturer of fluoroscopic imaging systems and from 1987 to 1990 he was President and Chief Operating Officer of Diasonics, a manufacturer of diagnostic imaging equipment. Dr. Naumann-Etienne has served on the board of directors of Varian Medical Systems, Inc., a public medical device company, since 2003, and Encision Inc., a public medical device company, since October 2008. Dr. Naumann-Etienne also served as a director of Cardiac Science Corporation, a public medical device company, from September 2005 until December 2010, and Bio-Rad Laboratories, Inc., a public life science company, from October 2003 until December 2009. Dr. Naumann-Etienne holds a Ph.D. in International Finance from the University of Michigan. He holds a Master’s Degree in Industrial Management from the Georgia Institute of Technology and holds an undergraduate degree in Business Administration from the Technical University Berlin, Germany. |
Basic Compensation
| Name | Fiscal Year Total |
|---|---|
William Moore |
-- |
James Mackaness |
412,696 |
Eduardo Arias |
335,549 |
Scott Shuda |
-- |
Sanford Fitch |
-- |
Garrett Garrettson |
-- |
James Hawkins |
-- |
Ruediger Naumann-Etienne |
-- |
As Of 30 Dec 2011
Options Compensation
| Name | Options | Value |
|---|---|---|
William Moore |
0 | 0 |
James Mackaness |
0 | 0 |
Eduardo Arias |
95,000 | 219,347 |
Scott Shuda |
0 | 0 |
Sanford Fitch |
0 | 0 |
Garrett Garrettson |
0 | 0 |
James Hawkins |
0 | 0 |
Ruediger Naumann-Etienne |
0 | 0 |
| Name | Shares Traded | Price |
|---|---|---|
NAUMANN ETIENNE RUEDIGER |
2,400 | $4.80 |
MOORE WILLIAM MARTIN |
5,800 | $4.63 |
ARIAS EDUARDO |
1,877 | $0.90 |
ARIAS EDUARDO |
1,075 | $4.63 |
MOORE WILLIAM MARTIN |
1,700 | $4.60 |
MOORE WILLIAM MARTIN |
2,500 | $4.79 |
MACKANESS JAMES H |
3,000 | $4.49 |
MACKANESS JAMES H |
3,000 | $2.49 |
MACKANESS JAMES H |
3,000 | $2.49 |
MACKANESS JAMES H |
3,000 | $4.61 |
MACKANESS JAMES H |
3,000 | $2.49 |
MACKANESS JAMES H |
3,000 | $4.79 |
MACKANESS JAMES H |
3,000 | $2.49 |
MACKANESS JAMES H |
3,000 | $4.70 |
MACKANESS JAMES H |
3,000 | $4.83 |
MACKANESS JAMES H |
3,000 | $2.49 |
MACKANESS JAMES H |
3,000 | $2.49 |
MACKANESS JAMES H |
3,000 | $4.73 |
MACKANESS JAMES H |
3,000 | $4.49 |
MACKANESS JAMES H |
3,000 | $2.49 |
MACKANESS JAMES H |
3,000 | $2.49 |
MACKANESS JAMES H |
3,000 | $4.66 |
MACKANESS JAMES H |
3,000 | $4.71 |
MACKANESS JAMES H |
3,000 | $2.49 |
MACKANESS JAMES H |
3,000 | $4.71 |
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
